Increased susceptibility of hypertrophied hearts to ischemic injury

Annals of Thoracic Surgery

Volumn 75, Issue 2, 2003, Pages

  Friehs, Ingeborg ^a   Del Nido, Pedro J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CALCIUM SIGNALING; CONFERENCE PAPER; CONTROLLED STUDY; HEART CONTRACTION; HEART DILATATION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART STRESS; HEART WORK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REPERFUSION INJURY;

ANIMALS; ANIMALS, NEWBORN; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENDOTHELIUM, VASCULAR; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HYPERTROPHY, LEFT VENTRICULAR; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; RABBITS; VENTRICULAR REMODELING;

EID: 0037312402     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(02)04692-1     Document Type: Conference Paper

References (70)

1. Morales AR, Fine G, Taber RE. Cardiac surgery and myocardial necrosis. Arch Pathol 1967;83:71-9.
2. Cooley DA, Reul GJ, Wukasch DC. Ischemic contracture of the heart: "stone heart". Am J Cardiol 1972;29:575-7.
3. Bull C, Cooper J, Stark J. Cardioplegic protection of the child's heart. J Thorac Cardiovasc Surg 1984;88:287-3.
4. del Nido PJ, Mickle DA, Wilson GJ, et al. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 1988;95:223-9.
5. del Nido PJ, Benson LN, Mickle DA, Kielmanowicz S, Coles JG, Wilson GJ. Impaired left ventricular postischemic function and metabolism in chronic right ventricular hypertrophy. Circulation 1987;76:V168-73.
6. Ho KK, Levy D, Kannel WB, Pinsky JL. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993;22:6-13.
7. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983;75:4-11.
8. Mehta RH, Bruckman D, Das S, et al. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 2001;122:919-28.
9. Orsinelli DA, Aurigemma GP, Battista S, Krendel S, Gaasch WH. Left ventricular hypertrophy and mortality after aortic valve replacement for aortic stenosis: a high risk subgroup identified by preoperative relative wall thickness. J Am Coll Cardiol 1993;22:1679-83.
10. Allard MF, Flint JD, English JC, et al. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol 1994;26:1551-63.
11. Sink JD, Pellom GL, Currie WD, et al. Response of hypertrophied myocardium to ischemia: correlation with biochemical and physiological parameters. J Thorac Cardiovasc Surg 1981;81:865-72.
12. Quantz M, Tschervenkov C, Chiu RC. Unique responses of immature hearts to ischemia. Functional recovery versus initiation of contracture. J Thorac Cardiovasc Surg 1992;103:927-35.
13. Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: mechanisms and prevention. Am J Cardiol 1977;39:986-93.
14. Snoeckx LH, van der Vusse GJ, Coumans WA, Reneman RS. The effects of global ischemia and reperfusion on compensated hypertrophied rat hearts. J Mol Cell Cardiol 1990;22:1439-52.
15. Anderson PG, Allard MF, Thomas GD, Bishop SP, Digerness SB. Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts. Circ Res 1990;67:948-59.
16. Bladergroen MR, Takei H, Christopher TD, Cummings RG, Blanchard SM, Lowe JE. Accelerated transmural gradients of energy compound metabolism resulting from left ventricular hypertrophy. J Thorac Cardiovasc Surg 1990;100:506-16.
17. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 1994;267:H742-50.
18. Kagaya Y, Kanno Y, Takeyama D, et al. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study. Circulation 1990;81:1353-61.
19. Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 1970;218:153-9.
20. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 1988;11:416-26.
21. Allard MF, Henning SL, Wambolt RB, Granleese SR, English DR, Lopaschuk GD. Glycogen metabolism in the aerobic hypertrophied rat heart. Circulation 1997;96:676-82.
22. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999;99:578-88.
23. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997;33:243-57.
24. Young HH, Shimizu T, Nishioka K, Nakanishi T, Jarmakani JM. Effect of hypoxia and reoxygenation on mitochondrial function in neonatal myocardium. Am J Physiol 1983;245:H998-1006.
25. Takeuchi K, Buenaventura P, Cao-Danh H, et al. Improved protection of the hypertrophied left ventricle by histidine-containing cardioplegia. Circulation 1995;92(Suppl):II395-9.
26. Takeuchi K, McGowan FX Jr, Glynn P, et al. Glucose transporter upregulation improves ischemic tolerance in hypertrophied failing heart. Circulation 1998;98(Suppl):II234-9.
27. Pessin JE, Bell GI. Mammalian facilitative glucose transporter family: structure and molecular regulation. Annu Rev Physiol 1992;54:911-30.
28. Stephens J, Pilch PF. The metabolic regulation and vesicular transport of GLUT-4, the major insulin-responsive glucose transporter. Endocr Rev 1995;16:529-46.
29. Kahn BB. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest 1992;89:1367-74.
30. Friehs I, Cao-Danh H, Stamm C, Cowan DB, McGowan FX, del Nido PJ. Post-natal increase in insulin-sensitive glucose transporter expression is associated with improved recovery of post-ischemic myocardial function. J Thorac Cardiovasc Surg (in press).
31. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE. Translocation of the glucose transporter GLUT4 in cardiac myocytes of the rat. Proc Natl Acad Sci USA 1991;88:7815-9.
32. Sun D, Nguyen N, Degrade TR, Schwaiger M, Brosius FC III. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT-4 to the plasma membrane of cardiac myocytes. Circulation 1994;89:793-8.
33. Friehs I, Moran AM, Stamm C, et al. Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure. Circulation 1999;100(Suppl):II187-93.
34. Friehs I, Stamm C, Cao-Danh H, McGowan FX, del Nido PJ. Insulin-like growth factor-1 improves postischemic recovery in hypertrophied hearts. Ann Thorac Surg 2001;72:1650-6.
35. Kanazawa Y, Momozono Y, Ishikawa M, et al. Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR. Life Sci 1986;39:737-42.
36. Allard MF, Wambolt RB, Longnus SL, et al. Hypertrophied rat hearts are less responsive to the metabolic and functional effects of insulin. Am J Physiol 2000;279:E487-93.
37. Kubler W, Spieckermann PG. Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol 1970;1:351-77.
38. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 1990;66:546-53.
39. Stanley WC, Hall JL, Hacker TA, Hernandez LA, Whitesell LF. Decreased myocardial glucose uptake during ischemia in diabetic swine. Metabolism 1997;46:168-72.
40. Paternostro G, Clarke K, Heath J, Seymour AM, Radda GK. Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res 1995;30:205-11.
41. Paolisso G, Galzerano D, Gambardella A, et al. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest 1995;25:529-33.
42. Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 1999;42:246-53.
43. Anderson PG, Bishop SP, Digerness SB. Transmural progression of morphologic changes during ischemic contracture and reperfusion in the normal and hypertrophied rat heart. Am J Pathol 1987;129:152-67.
44. Gaasch WH, Zile MR, Hoshino PK, Weinberg EO, Rhodes DR, Apstein CS. Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy. Circulation 1990;81:1644-53.
45. Eberli FR, Weingberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991;68:466-81.
46. Vanoverschelde JL, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol 1994;267:H1785-94.
47. Poggi C, Le Marchand-Brustel Y, Zapf J, Froesch ER, Freychet P. Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology 1979;105:723-30.
48. Hussain MA, Schmitz O, Mengel A, et al. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 1993;92:2249-56.
49. Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 1996;45:91-100.
50. Bilan PJ, Ramlal T, Klip A. IGF-I mediated recruitment of glucose transporters from intracellular membranes to plasma membranes in L6 muscle cells. Adv Exp Med Biol 1991;293:273-88.
51. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-8.
52. Tyagi SC, Kumar S, Voelker DJ, Reddy HK, Janicki JS, Curtis JJ. Differential gene expression of extracellular matrix components in dilated cardiomyopathy. J Cell Biochem 1996;63:185-98.
53. Motz W, Strauer BE. Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 1989;13:43-50.
54. Iimotot DS, Covell JW, Harper E. Increase in cross-linking of type I and type III collagens associated with volume-overload hypertrophy. Circ Res 1988;63:399-408.
55. Zimmer HG, Peffer H. Metabolic aspects of the development of experimental cardiac hypertrophy. Basic Res Cardiol 1986;81(Suppl 1):127-37.
56. Tomanek RJ, Palmer PJ, Peiffer GL, Schreiber KL, Eastham CL, Marcus ML. Morphometry of canine coronary arteries, arterioles, and capillaries during hypertension and left ventricular hypertrophy. Circ Res 1986;58:38-46.
57. Bache RJ, Vrobel TR, Ring WS, Emery RW, Andersen RW. Regional myocardial blood flow during exercise in dogs with chronic left ventricular hypertrophy. Circ Res 1981;48:76-87.
58. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res 1989;65:971-80.
59. Marcus ML, Harrison DG, Chilian WM, et al. Alterations in the coronary circulation in hypertrophied ventricles. Circulation 1987;75:I19-25.
60. Batra S, Rakusan K. Capillary network geometry during postnatal growth in rat hearts. Am J Physiol 1992;262:H635-40.
61. Turek Z, Rakusan K. Lognormal distribution of intercapillary distance in normal and hypertrophic rat heart as estimated by the method of concentric circles: its effect on tissue oxygenation. Pflügers Arch 1981;391:17-21.
62. Greene AS, Tonellato PJ, Lui J, Lombard JH, Cowley AW Jr. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol 1989;256:H126-31.
63. Thurston G, Baluk P, Hirata A, McDonald DM. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol 1996;271:H2547-62.
64. Friehs I, Stamm C, Moran AM, et al. Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury. Surg Forum 2001;LII:64-5.
65. Takeshita S, Gal D, Leclerc G, et al. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest 1994;93:662-70.
66. Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9.
67. Schumacher B, Pecher P, von Specht U, Stegmann Th. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998;97:645-50.
68. Hendel RC, Henry TD, Rocha-Singh K, et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation 2000;101:118-21.
69. Vale PR, Losordo DW, Milliken CE, et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001;103:2138-43.
70. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.